You may search any word / name within the scientific program by simply writing it in the abowe search box and clicking ‘Enter’. Please note that when you make a search, the results are coming under each day and each hall separately. Therefore, please make sure to look into different days & halls when you are making a search.
AEPC 2022 SCIENTIFIC PROGRAM OVERVIEW
Due to continuous changes, the immediate updates can be done on the web version of the program (displayed below) while the PDF file is updated on a weekly basis. If the PDF is showing the most recent updates, please wait for a few days to have it updated as well.
Please click the below buttons to reach the scientific program that you would like to view.
WG Sessions | Abstract Sessions | Nursing Sessions |
Moderated Posters | Plenary & Keynote Lectures | Business Meetings |
16:00 - 17:30 |
OPENING CEREMONY MANNHEIMER LECTURE |
08:00 - 16:00 |
UPDATE COURSE Course registration is required to attend the Update Course program. |
08:00 - 16:00 |
NURSING EDUCATION DAY Separate registration is required for Nursing Educational Day Program. |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 11:00 | AEPC BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
S01 Chair: Tara Bharucha, UK Assessing the connections in a Fontan patient, |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:30 - 16:00 |
S07 Chair: Joan Sanchez-de-Toledo, Spain Pre and postoperative indications for ECMO |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
S11 Chair: Xavier Iriart, France Fibrosis Imaging in repaired ToF - clinical correlates, |
08:00 - 09:00 | BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
S02 Chair: Marc Gewillig, Belgium PDA, Alain Fraisse, UK |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:30 - 16:00 |
S08 Chair: Massimo Chessa, Italy Outcome of the Fontan already converted, |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
S12 Chair: Mirella Molenschot, Netherlands What the interventionalist needs to know before entering the cathlab, |
08:00 - 09:00 | BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
S03 Chair: Daniel De Wolf, Belgium New drugs in heart failure, |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
13:00-14:30 |
S06 Chair: Adam Kolesnik, Poland Congenital malformations with systemic right ventricle, |
14:30-16:00 |
S09 Chair: Hiroyoki Yamagishi, Japan Dynamic contrast enhanced magnetic resonance lymphangiography: Informative imaging approach to lymphatic disorders in Fontan circulation, |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
S13 Chair: Michael J Ackerman, United States Syncope, |
08:00 - 09:00 | BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
S04 Chair: Eva Grohmann, Austria Morphology of the Tricuspid valve, Tricuspid Dysplasia, Anatomy of Particular Abormalities, |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:30 - 16:00 |
S10 Chair: Sabine Klaassen, Germany Antiarrhythmic therapy, |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
MP01 P-429 Paediatric and Adult Congenital Cardiology Training In Europe, Colin J Mcmahon, Ireland P-455 Oscillometric pulse-wave-velocity measurement in adult and pediatric cohorts shows an excellent accuracy – An evaluation study of the Mobil-O-Graph, Matthias Walser, Germany P-447 Hidden cardiovascular morbidity in children and young adults born with Congenital diaphragmatic hernia: A Population-based study, Katarina Övermo Tydén, Sweden P-405 Pediatric Cardiology Fellowship Programs in countries with limited resources: Achievements and Challenges, Sulafa K Ali, Sudan P-037 Foetal Tricuspid Valve Agenesis/Atresia: Testing Predictions of the Embryonic Aetiology, Marieke F. J. Buijtendijk, Netherlands P-263 Systemic small vessel disease following pediatric heart transplantation, Constance G Weismann, Germany P-277 Differences between QRS-T angle in children with idiopathic dilated cardiomyopathy - a pilot study, Katarzyna Luczak Wozniak, Poland P-494 Infections predispose Kawasaki Disease, a nationwide population-based case-control study of incident cases 1987-2018 in Sweden, Andre Rudolph, Sweden P-495 Preliminary results of follow-up of patients with multisystem inflammatory syndrome associated with Covid-19, Loudmila Bregel, Russia P-505 Adolescents with CHD. -Is their illness perception impacting Quality of life?, Åsa Burström, Sweden |
08:00 - 09:00 | BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
S05 Chair: Peter Fritsch, Austria Coronary Anomlies- Morphology and demo – identification of patterns at risk, |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
13:30-14:30 |
*Session will be in Salle 14, Floor 2 Junior interventionalists meet seniors One learns by experience - How I became an interventional cardiologist Daniel de Wolf, Belgium |
14:30 - 16:00 |
AS02 O-007 What’s in a shape? Predicting neonatal coarctation of the aorta using 3D statistical shape models of normal and abnormal fetal arch morphology, |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
S14 Chair: Peter Fritsch, Austria The ECG in the paediatric athlete – do we need new reference values ?, |
08:00 - 09:00 | BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
AS01 O-001 Defining Genotype-Phenotype Correlation in Paediatric Patients With Hypertrophic Cardiomyopathy, |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:30 - 16:00 |
AS03 O-013 Piggyback Mounting for Stent and Valve Deployment during percutaneous pulmonary valve implantation, |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
AS04 Pulmonary Hypertension in Adults with Congenital Heart Disease: Updated and Extended Results from the International COMPERA-CHD Registry, |
08:00 - 09:00 | BUSINESS MEETING |
11:00 - 11:30 | BREAK |
11:30 - 13:00 |
NS01 Chair: Lynda Shaughnessy, UK Management of children with CHD during a COVID-19 pandemic: lessons learned, |
13:00 - 14:30 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:30 - 16:00 |
NS02 Chair: Katya De Groote, Belgium When and how to start to talk about genetics and risk of pregnancy in a youngster with CHD?, |
16:00 - 16:30 | BREAK |
16:30 - 18:00 |
NS03 O-025 Oral breastmilk is safe pre- and early post-operatively in babies with Coarctation of the Aorta, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S15 Chair: Annika Ohmann, Sweden Fetal Cardiac Assessment of the borderline LV, |
10:30 - 11:00 | BREAK |
11:30 - 12:30 |
AS06 Fetal cardiology O-037 Fetal complications associated with fetal cardiac interventions: experience of 205 procedures, |
12:30 - 14:00 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:00 - 15:30 |
S21 Chair: Grazyna Brzezinska-Rajszys, Poland Morphological specimen vs 3D-printed and virtual models – educational perspective, |
15:30 - 16:00 | BREAK |
16:00 - 17:30 |
S26 SARS-CoV-2: Impact in the cardio-pulmonary circulation, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S16 Chair: Hannes Sallmon, Germany Delivering patient centred care to adults with congenital heart disease and heart failure – what we can learn from the Covid 19 pandemic, |
10:30 - 11:00 | BREAK |
11:30 - 12:30 |
AS07 O-043 Transcatheter creation of a restrictive atrial communication for treatment of patients with heart failure and hypertensive left atrial pressures, |
12:30 - 14:00 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:00 - 15:30 |
S23 Chair: Maurice Beghetti, Switzerland Rising to the challenge, this intervention can really delay transplant, |
15:30 - 16:00 | BREAK |
16:00 - 17:30 |
S27 Disruption of sodium-dependent vitamin transport: a potential novel cause of cardiomyopathy, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
Young Investigator Award Chair: Ina Michel-Behnke, Austria O-031 Transcatheter Correction of Sinus Venosus Atrial Septal Defect: From Bench Testing to Clinical Success |
10:30 - 11:00 | BREAK |
11:00 - 11:30 |
"HAUSDORF LECTURE" |
11:30 - 12:30 |
AS08
|
12:30 - 14:00 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
12:30 - 14:00 |
S20 Chair: Annalisa Angelini, Italy Isolated patent ductus arteriosus, |
14:00 - 15:30 |
S22 Incidence, symptomatology and outcome of cardiac tumors in the pediatric age group,
|
15:30 - 16:00 | BREAK |
16:00 - 17:30 |
S28 The REV procedure, superior to the Rastelli operation., |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S18 Chair: Martin Koestenberger, Austria State of the Art in Diagnostics in PAH, |
10:30 - 11:00 | BREAK |
11:30 - 12:30 |
MP02 P-148 Different profiles of lipoprotein particles associate various degree of cardiac involvement in adolescents with morbid obesity, José Manuel Siurana, Spain P-144 Impact of lockdown on cardiopulmonary function in children with heart disease, Isabelle Schöffl, Germany P-155 Association between objectively measured physical activity and exercise capacity in children with congenital heart disease, Laura Willinger, Germany P-139 Preclinical aortic atherosclerosis in adolescents with chronic disease, Henk Schipper, Netherlands P-156 Effect of physical activity on cardiovascular health in six-year-old children born to mothers with high cardiometabolic risk, Linda Litwin, Poland P-130 Risk Factors for Perioperative Brain Lesions on MRI in Infants with Severe Congenital Heart Disease: A European Collaboration, Alexandra Bonthrone, UK P-150 Motor function in children and adolescents with CHD in a direct twin comparison – same same, but different?, Julia Remmele, Germany P-169 Adverse arterioventricular interaction in adolescents with chronic disease, Victor Verpalen, Netherlands P-134 Common carotid artery characteristics in patients with repaired aortic coarctation compared to other cardiovascular risk factors, Constance G Weismann, Germany P-159 COVID-19 vaccination from 6 to 17 years carries a similar risk for fatal or life-threatening myocarditis than being struck by lightning, Massimiliano Cantinotti , Italy P-145 Investigating the relation between hemoglobin a1c with left ventricular remodeling patterns in children with type 1 diabetes mellitus, Iulia Rodoman, Moldova P-138 1. Lack of improvement in the postnatal detection of heart defects, Gunnar Wik, Norway |
12:30 - 14:00 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:00 - 15:30 |
MP04 P-489 Determining factors for hs-Troponin T and NT-proBNP in a cohort of healthy children (The LIFE child study), Alexandra Kiess, Germany P-353 Surgical Treatment of the Aortic Coarctation Depending on the Anatomical Characteristics, Hyungtae Kim, South Korea P-372 Health-Related Quality of Life of Ugandan Children following Valve Replacement Surgery for Rheumatic Heart Disease., Mohammed Ahmed Mohammed, Turkey P-370 Factors associated with acute kidney injury after cardiopulmonary bypass in children, Michael Nicolas Gritti, Canada P-017 Bioelectrical impedance analysis as a potential risk marker in adults with Marfan syndrome, Mathieu Suleiman, Germany P-009 Home-based resistance training in Fontan patients: it’s feasible, safe and efficient!, Joanie Gagnon, Canada P-168 Nutritional Diagnosis in children with congenital heart disease and parental characteristics in a social program in a Latin American country, Victor M. H. Quinones, Colombia P-135 Does pulse wave analysis by digital plethysmography reliably assess arterial stiffness in patients with congenital heart disease?, Constance G Weismann, Germany |
15:30 - 16:00 | BREAK |
16:00 - 17:30 |
S29 ICD in primary prevention for the systemic RV: who and when?, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S19 Chair: Roberto Di Donato, Italy The true anatomy of the L-TGA, |
10:30 - 11:00 | BREAK |
11:30 - 12:30 |
AS09 Chair: Stefano Di Bernardo, Switzerland O-055 Ductus arteriosus stenting versus Blalock-Taussig shunt for infants with ductal-dependent pulmonary circulation: a comparative international study |
12:45 - 13:45 |
NS06 Being in the right place at the right time over 40 years in pediatric cardiology: Lessons learned and ways forward Chair: Gaby Stoffel, Switzerland |
14:00 - 15:30 |
S24 Chair: Joachim Hebe, Germany |
15:30 - 16:00 | BREAK |
16:00 - 17:30 |
S30 Vlasta Fesslova, Italy |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S17 Chair: Kenny Wong, Canada The echo findings related to need for and results of resynchronization therapy, |
10:30 - 11:00 | BREAK |
11:30 - 12:30 |
MP03 Cardiac Dysrhythmias and Electrophysiology & Genetics, Basic Science and Myocardial Disease Chair: Alice Maltret, France P-217 AVNRT cryoablation in children < 26 Kg: efficacy and safety of electrophysiologically guided low voltage bridge strategy, Cristina Raimondo, Italy P-248 Clinical characteristics and mid-term follow-up findings in children with isolated complete heart block: A single-center ten-year experience, Yakup Ergul, Turkey P-254 Clinical course and electrophysiological characteristics of permanent junctional reciprocating tachycardia in children: ten years experience, Yakup Ergul, Turkey P-207 Two broken pacemaker cans in one patient, Anna Cavigelli Brunner, Switzerland P-247 Epicardial device migration in children – a rare but important complication, Tomasz Marcin Ksiazczyk, Poland P-225 Catheter ablation of accessory pathways in children and patients with congenital heart disease: Predictors of outcome, John Papagiannis, Greece P-257 Cardioneuroablation in a pediatric patient with Type IIb cardioinhibitory vasovagal syncope and functional advanced AV block, Yakup Ergül, Turkey P-476 Clinical symptoms in children with genetic aortopathy and their response to medical therapy – A monocentric analysis over more than one decade, Jakob Olfe, Germany P-487 Induced pluripotent stem cell-derived Chagas disease model highlights the role of cardiomyocytes as sentinels of the host-parasite interaction, Yu Nakagama, Japan P-472 Homozygous Genetic Variant in Desmin Causes Severe Inflammatory Cardiomyopathy, Franziska Seidel, Germany P-479 Arrhythmia and impaired myocardial function in Heritable Thoracic Aortic Disease: an international retrospective cohort study, Laura Muiño Mosquera, Belgium P-474 Concerns about safety of growth hormone therapy in Noonan syndrome and other RASopathies: risk of triggering or worsening hypertrophic cardiomyopathy, Ingegerd Östman Smith, Sweden |
12:30 - 14:00 |
AS05 Chair: Christian Balmer, Switzerland O-061 Electrocardiographic and electrophysiological characteristics of fasciculoventricular fibers in children: Single-center 8-years experiencei |
14:00 - 15:30 |
S25 Chair: Margarita Bartsota, Cyprus Feasibility of non-gated dynamic fetal cardiac MRI for identification of fetal cardiovascular anatomy, |
15:30 - 16:00 |
BREAK |
16:00 - 17:30 |
S31 Chair: Nicole Sekarski, Switzerland Artificial intelligence in the Cardiac Intensive Care, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
NS04 Chair: Damien Bonnet, France How to manage problems affecting long-term outcomes after heart transplantation, |
10:30 - 11:00 | BREAK |
11:30 - 12:30 |
NS05 Chair: Justyna Rybicka, UK Pre-operative Information: perspectives of patients, family and healthcare teams, |
12:30 - 14:00 | LUNCH BREAK / JUNIOR SESSIONS / COMMITTEE MEETINGS / INDUSTRY SESSIONS |
14:00 - 15:30 |
AS10 Chair: Albane Maggio, Switzerland O-067 Physical fitness, BMI, health-related quality of life and mental concentration – Cross-sectional cardiovascular risk data of a large school cohort, |
15:30 - 16:00 | BREAK |
16:00 - 17:30 |
AS11 Chair: Walter Knirsch, Switzerland O-073 Congenital heart defects and their association with maternal diabetes and overweight during pregnancy: a register-based study from Finland, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S32 Chair: Carrie Altman, United States How to prevent errors?, |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
S36 Chair: Lars Sondergaard, Denmark Melody Harmony Valve, |
12:30 - 13:30 |
KEYNOTE LECTURE & CLOSING |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S33 Chair: Regina Bokenkamp, Netherlands Million Pound boy, Sonia EL Saiedi, Egypt |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
S37 Chair: Michal Odermarsky, Sweden Biomarkers in congenital heart disease, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S34 Chair: Werner Budts, Belgium The arterial switch procedure: really that good?, |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
S38 Chair: Joanna Dangel, Poland Development and morphology of RV in subpulmonary and subsystemic position, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
AS12 Chair: Damian Hutter, Switzerland O-079 A bicentric propensity matched analysis of 158 patients comparing porcine versus bovine stented bioprosthetic valves in pulmonary position, |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
MP05 Chair: Oliver Kretschmar, Switzerland
|
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
S35 Chair: Martin Köstenberger, Austria Risk Stratification in Paediatric Pulmonary Hypertension, |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
S39 Chair: Fabrizio Drago, Italy Expert Consensus Statement on the Indications and Management of CIED in Pediatric Patients – what is new?, |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
AS13 Chair: Birgit Donner, Switzerland O-085 Typical AVNRT - underestimated arrhythmia after atrial redirection surgery for d-transposition of the great arteries? 20 years of catheter ablation, |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
AS14 Chair: Tornike Sologashvili, Switzerland O-091 Short to long-Term outcome of patients implanted with a telemetric adjustable pulmonary artery banding device FloWatch-PAB® in Switzerland, Sara Valerie De Meyer, Switzerland |
08:00 - 09:00 | BUSINESS MEETING |
09:00 - 10:30 |
Chair: Ewa-Lena Bratt, Sweden Neurodevelopmental outcomes, |
10:30 - 11:00 | BREAK |
11:00 - 12:30 |
AS15 O-097 Three-dimensional echocardiography and global longitudinal strain in the assessment of left ventricular function in children after PIMS-TS, |